Want to see IN:RAMAPHO full AI Analyst Report?
Top Page
Rama Phosphates Limited
(RAMAPHO)
Select Model
Select Model
Rating:56Neutral
Price Target:
₹126.00
▼(-26.36% Downside)
Action:Reiterated
Date:05/21/26
The score is driven primarily by mixed financial performance: a notable 2026 earnings rebound and acceptable leverage are offset by weak, volatile cash generation. Technicals are a headwind with a broadly bearish trend despite oversold readings, while valuation (low P/E) provides some support.
Positive Factors
2026 revenue rebound
A sharp revenue rebound in 2026 shows the business can recover volumes and/or pricing after a downturn, indicating operational resilience. Sustained top-line recovery supports margin leverage and funding capacity for medium-term investments if management preserves discipline.
Negative Factors
Volatile and weak cash generation
Repeated negative operating cash flow and swingy free cash flow undermine the sustainability of reported profits. Uneven cash conversion raises risk that earnings are working-capital or timing-driven, requiring external funding for capex or dividends and limiting durable value creation.
Read all positive and negative factors
Positive Factors
Negative Factors
2026 revenue rebound
A sharp revenue rebound in 2026 shows the business can recover volumes and/or pricing after a downturn, indicating operational resilience. Sustained top-line recovery supports margin leverage and funding capacity for medium-term investments if management preserves discipline.
Read all positive factors
Rama Phosphates Limited (RAMAPHO) vs. iShares MSCI India ETF (INDA)
Market Cap
₹4.39B
Dividend Yield0.46%
Average Volume (3M)27.40K
Price to Earnings (P/E)8.2
Beta (1Y)1.64
Revenue Growth20.08%
EPS Growth180.73%
CountryIN
Employees510
SectorGeneral
Sector StrengthN/A
IndustryAgricultural Inputs
Share Statistics
EPS (TTM)14.89
Shares Outstanding35,302,460
10 Day Avg. Volume67,288
30 Day Avg. Volume27,403
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.87
Price to Sales (P/S)0.41
P/FCF Ratio-27.28
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Rama Phosphates Limited Business Overview & Revenue Model
Company Description
Operating within India, Rama Phosphates Limited functions as a manufacturer and supplier of agricultural inputs, including various fertilizers and micronutrients, alongside a range of chemicals and soya-based products. The company's business activ...
How the Company Makes Money
null...
Rama Phosphates Limited Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
68
Positive
Cash Flow
41
Neutral
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 8.93B | 5.15B | 4.33B | 5.71B | 4.90B |
| Gross Profit | 2.41B | 2.23B | -720.70M | -975.08M | -1.13B |
| EBITDA | 888.33M | 434.25M | -207.22M | 722.57M | 1.14B |
| Net Income | 527.09M | 136.75M | -310.67M | 409.34M | 700.37M |
Balance Sheet | |||||
| Total Assets | 7.19B | 6.34B | 6.26B | 5.34B | 4.43B |
| Cash, Cash Equivalents and Short-Term Investments | 115.06M | 36.69M | 73.65M | 62.42M | 17.57M |
| Total Debt | 1.39B | 1.26B | 1.49B | 1.18B | 588.47M |
| Total Liabilities | 2.97B | 2.63B | 2.73B | 2.25B | 1.73B |
| Stockholders Equity | 4.22B | 3.71B | 3.53B | 3.09B | 2.70B |
Cash Flow | |||||
| Free Cash Flow | -135.16M | 324.44M | -131.67M | -464.73M | -429.47M |
| Operating Cash Flow | 110.75M | 399.05M | -51.04M | -362.60M | -85.82M |
| Investing Cash Flow | -225.24M | -41.33M | -115.35M | -81.45M | -316.63M |
| Financing Cash Flow | 114.34M | -358.86M | 164.22M | 447.50M | 402.07M |
Rama Phosphates Limited Technical Analysis
Negative
171.10
Price Trends
126.67
Negative
126.85
Negative
147.38
Negative
Market Momentum
-0.44
Positive
47.24
Neutral
30.11
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:RAMAPHO, the sentiment is Negative. The current price of 171.1 is above the 20-day moving average (MA) of 127.02, above the 50-day MA of 126.67, and above the 200-day MA of 147.38, indicating a bearish trend. The MACD of -0.44 indicates Positive momentum. The RSI at 47.24 is Neutral, neither overbought nor oversold. The STOCH value of 30.11 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:RAMAPHO.
Rama Phosphates Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | ₹181.66B | 9.31 | ― | 2.13% | 24.92% | 18.44% | |
64 Neutral | ₹9.90B | 1.08 | ― | ― | -27.87% | 458.30% | |
58 Neutral | ₹611.17B | 30.96 | ― | 0.50% | 30.70% | -5.33% | |
56 Neutral | ₹4.39B | 8.23 | ― | 0.46% | 20.08% | 180.73% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
53 Neutral | ₹146.95B | 13.39 | ― | 0.62% | 52.51% | 56.28% | |
53 Neutral | ₹70.92B | 16.83 | ― | 0.93% | 9.13% | 76.20% |
* General Sector Average
IN:RAMAPHO
Rama Phosphates Limited
122.15
-20.45
-14.34%
IN:CHAMBLFERT
Chambal Fertilisers & Chemicals Ltd.
453.70
-87.23
-16.13%
IN:COROMANDEL
Coromandel International Limited
2,057.60
-302.85
-12.83%
IN:PARADEEP
Paradeep Phosphates Ltd.
141.60
-31.11
-18.01%
IN:RCF
Rashtriya Chemicals & Fertilizers Ltd.
130.50
-23.66
-15.35%
IN:ZUARI
Zuari Agro Chemicals Ltd.
236.05
30.65
14.92%
Rama Phosphates Limited Corporate Events
Rama Phosphates Shareholders Clear Second Term for Independent Director Ratneshwar Prasad
Apr 2, 2026
Rama Phosphates Limited has announced that its shareholders have approved the re-appointment of Mr. Ratneshwar Prasad as an Independent Director for a second five-year term from May 30, 2026 to May 29, 2031, via a postal ballot conducted through r...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.